Anaroxyl2.5 mg
Tablet
Monosemicarbazone Adrenochrome
Nuvista Pharma Ltd.
Product Code : 970
10% Off
Best PriceTk
/
1
Medicine overview
Indications of Anaroxyl 2.5 mg
Anaroxyl 2.5 mg is indicated in the prevention and treatment of surgical and non-surgical capillary bleedings.
Theropeutic Class
Anti-fibrinolytic drugs
Pharmacology
Adrenochrome Monosemicarbazone is a haemostatic with a rapid onset of action. It contains a water soluble form of adrenochrome monosemicarbazone, a stable derivative of adrenochrome as the active substance. Adrenochrome is an oxidation product of adrenaline; it reduces normal and pathologic bleeding time by decreasing capillary permeability. It produces capillary haemostatis without exerting any of the adrenergic actions on respiration or cardiovascular system. Thus, despite its adrenaline like action on small blood vessels, does not give rise to the general systemic effects of sympathomimetic drugs.
Dosage & Administration of Anaroxyl 2.5 mg
For the prevention and treatment of capillary bleedings, accordingly to the severity of the case, 4-12 tablets divided over the day, preferably one hour before meals. Prior to surgery, medication is started on the preceding evening, either orally or by intramuscular or subcutaneous injection of usually 1.5-5 mg. In addition, an injection is given about half an hour before the surgical intervention.Injection solution should be administered by intramuscular or subcutaneous route; in emergency cases the injections may be given intravenously. The tablets should be taken orally.
Dosage of Anaroxyl 2.5 mg
For the prevention and treatment of capillary bleedings, accordingly to the severity of the case, 4-12 tablets divided over the day, preferably one hour before meals. Prior to surgery, medication is started on the preceding evening, either orally or by intramuscular or subcutaneous injection of usually 1.5-5 mg. In addition, an injection is given about half an hour before the surgical intervention.Injection solution should be administered by intramuscular or subcutaneous route; in emergency cases the injections may be given intravenously. The tablets should be taken orally.
Interaction of Anaroxyl 2.5 mg
No specific drug interaction has been demonstrated.
Contraindications
There are no known contraindications.
Side Effects of Anaroxyl 2.5 mg
No adverse reactions have been reported at the recommended dosages.
Pregnancy & Lactation
During pregnancy, the benefits of the use of Anaroxyl 2.5 mg should be weighed against the possible hazards of the foetus.
Precautions & Warnings
Because of the content of diprophylline (90 mg/ml), the dosage of the 5 mg/ml injection preparation to premature babies, infants and young children should not exceed 0.3 ml.
Storage Conditions
Store in a cool (in between 2°-25°C), dry place & protect from light. Keep out of the reach of children.
Drug Classes
Anti-fibrinolytic drugs
Mode Of Action
Adrenochrome Monosemicarbazone is a haemostatic with a rapid onset of action. It contains a water soluble form of adrenochrome monosemicarbazone, a stable derivative of adrenochrome as the active substance. Adrenochrome is an oxidation product of adrenaline; it reduces normal and pathologic bleeding time by decreasing capillary permeability. It produces capillary haemostatis without exerting any of the adrenergic actions on respiration or cardiovascular system. Thus, despite its adrenaline like action on small blood vessels, does not give rise to the general systemic effects of sympathomimetic drugs.
Pregnancy
During pregnancy, the benefits of the use of Anaroxyl 2.5 mg should be weighed against the possible hazards of the foetus.
Disclaimer
The information provided is accurate to our best practices, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy. The absence of specific information about a drug should not be seen as an endorsement. We are not responsible for any consequences resulting from this information, so consult a healthcare professional for any concerns or questions.